Laurion Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-524
| Closed | -$373K | – | 236 |
|
|
2024
Q4 | $373K | Buy |
+524
| New | +$373K | 0.01% | 112 |
|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$6.98M | – | 507 |
|
|
2022
Q1 | $6.98M | Buy |
+10,000
| New | +$6.98M | 0.09% | 59 |
|
|
2021
Q3 | – | Sell |
-443
| Closed | -$247K | – | 583 |
|
|
2021
Q2 | $247K | Buy |
+443
| New | +$247K | ﹤0.01% | 414 |
|
|
2021
Q1 | – | Sell |
-427
| Closed | -$206K | – | 624 |
|
|
2020
Q4 | $206K | Buy |
+427
| New | +$206K | ﹤0.01% | 382 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 798 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 678 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | -$55K | – | 769 |
|
|
2019
Q3 | $55K | Sell |
200
-4,452
| -96% | -$1.22M | ﹤0.01% | 552 |
|
|
2019
Q2 | $1.46M | Buy |
+4,652
| New | +$1.46M | 0.01% | 218 |
|
|
2019
Q1 | – | Sell |
-4,285
| Closed | -$1.6M | – | 837 |
|
|
2018
Q4 | $1.6M | Buy |
4,285
+20
| +0.5% | +$7.47K | 0.03% | 186 |
|
|
2018
Q3 | $1.72M | Sell |
4,265
-3,913
| -48% | -$1.58M | 0.02% | 242 |
|
|
2018
Q2 | $2.82M | Hold |
8,178
| – | – | 0.02% | 284 |
|
|
2018
Q1 | $2.82M | Buy |
8,178
+600
| +8% | +$207K | 0.02% | 305 |
|
|
2017
Q4 | $2.85M | Buy |
7,578
+2,900
| +62% | +$1.09M | 0.01% | 333 |
|
|
2017
Q3 | $2.09M | Sell |
4,678
-500
| -10% | -$224K | 0.01% | 370 |
|
|
2017
Q2 | $2.54M | Buy |
5,178
+1,520
| +42% | +$746K | 0.01% | 346 |
|
|
2017
Q1 | $1.42M | Buy |
3,658
+1,758
| +93% | +$681K | 0.01% | 281 |
|
|
2016
Q4 | $697K | Buy |
+1,900
| New | +$697K | 0.01% | 378 |
|